🇺🇸 fluticasone/salmeterol in United States

1,466 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 1,466

Most-reported reactions

1. Asthma — 277 reports (18.89%)
2. Dyspnoea — 257 reports (17.53%)
3. Wheezing — 166 reports (11.32%)
4. Therapeutic Product Effect Incomplete — 141 reports (9.62%)
5. Cough — 131 reports (8.94%)
6. Pneumonia — 120 reports (8.19%)
7. Drug Ineffective — 114 reports (7.78%)
8. Blood Count Abnormal — 91 reports (6.21%)
9. Chronic Obstructive Pulmonary Disease — 87 reports (5.93%)
10. Obstructive Airways Disorder — 82 reports (5.59%)

Source database →

Frequently asked questions

Is fluticasone/salmeterol approved in United States?

fluticasone/salmeterol does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for fluticasone/salmeterol in United States?

Hull University Teaching Hospitals NHS Trust is the originator. The local marketing authorisation holder may differ — check the official source linked above.